Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells
The active form of vitamin D, 1α,25-dihydroxyvitamin D 3 (1,25D), has a broad range of effects which are mediated by nuclear vitamin D receptor (VDR). Many experiments that investigate the role of VDR can be done in human acute myeloid leukemia (AML) cells, since these cells are responsive to 1,25D...
Saved in:
Published in | Journal of steroid biochemistry and molecular biology Vol. 121; no. 1; pp. 114 - 116 |
---|---|
Main Authors | , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.07.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The active form of vitamin D, 1α,25-dihydroxyvitamin D
3 (1,25D), has a broad range of effects which are mediated by nuclear vitamin D receptor (VDR). Many experiments that investigate the role of VDR can be done in human acute myeloid leukemia (AML) cells, since these cells are responsive to 1,25D and express VDR in a 1,25D-regulated manner. In this paper we show that in HL60 and in THP-1 cells VDR protein interacts with heat shock protein 90 (Hsp90) and that Hsp90 is important for differentiation of AML cells. Geldanamycin (GA), an Hsp90 inhibitor, is able to suppress 1,25-induced differentiation of HL60 cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-0760 1879-1220 |
DOI: | 10.1016/j.jsbmb.2010.01.013 |